# Seronegative Oligoarthritis of the Knee Study (SOKS)

> **NCT01216631** · PHASE2 · TERMINATED · sponsor: **University of Leeds** · enrollment: 1 (actual)

## Conditions studied

- Spondylarthropathies

## Interventions

- **DRUG:** methylprednisolone
- **DRUG:** Infliximab
- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT01216631
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Unable to recruit
- **Last updated:** 2016-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01216631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01216631, "Seronegative Oligoarthritis of the Knee Study (SOKS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01216631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*